Start here
An excision is what most skin cancers on the trunk, arms and legs get — numbing, a cut, stitches, a dressing, and home within the hour.
Why the scar is longer than the spot: To close a round hole flat without a pucker at each end, the piece taken out has to be an ellipse about three times as long as it is wide, so a spot the size of a pencil eraser becomes a scar an inch or more long.
The specimen goes to a laboratory and the result takes several days to a week. Most come back with clear margins; sometimes they do not, and a second procedure is needed — which is exactly what Mohs surgery avoids on the face.
— Dr. Schwarz, Board Certified Dermatologist
Key Facts
−
| Also called | Excisional surgery, elliptical excision, fusiform excision, wide local excision, standard surgical excision |
| Downtime | Home the same day. About 2 weeks of no lifting, straining or strenuous exercise |
| Sessions | One visit for the surgery and one short visit for stitch removal. A second procedure only if a margin comes back involved |
| Typical cost | More than a scrape-and-burn, less than Mohs. Generally covered by US health insurance when treating a diagnosed skin cancer. The laboratory bills separately |
| Results timeline | Pathology in about 3 to 10 days. Stitches out at 5 to 14 days. The scar keeps improving for about a year |
| Pain | The numbing injection stings for under a minute. Afterward the site feels tight and sore for a few days |
| Margins | Examined by a pathologist afterward, by taking slices across the specimen. Thorough, and not the same as examining every point along the edge |
| Cure rate | Commonly quoted around 95 percent at 5 years for a previously untreated basal cell carcinoma |
| Skin tone safety | The surgery is identical on every skin tone. Keloid and thickened scars are more likely and are the main thing to plan around |
What It Is
−
Cutting the growth out and stitching the skin back together. After local anesthetic, the surgeon draws an ellipse — a long pointed eye shape — around the growth, including a border of normal-looking skin measured in millimeters and set by the type of cancer. The ellipse is cut through the full thickness of the skin, sometimes into the fat beneath, and lifted out in one piece. Bleeding is stopped, the edges are freed slightly so they meet without pulling, and the wound is closed in layers: dissolving stitches underneath, then a line of stitches on the surface. The whole piece is sent to a laboratory, where a pathologist slices it, examines the slices, and reports whether the tumor came out fully and how close it came to the edges. That takes several days. The direction of the ellipse is chosen deliberately, along the natural lines of the skin, so the scar sits in a crease or fold and pulls as little as possible. It is used for essentially any skin cancer that does not need Mohs surgery — basal cell and squamous cell carcinomas on the trunk and limbs, melanoma — and for harmless growths such as cysts, lipomas and moles that need to come off.
How It Works
−
Two ideas make an excision work.
The first is the margin. These tumors grow outward from a visible center, with microscopic extensions reaching further than the eye can see. A measured border of normal-looking skin captures those extensions without knowing exactly where they went. The width is not arbitrary: a small low-risk basal cell carcinoma is usually taken with a few millimeters, squamous cell carcinoma with a little more, and melanoma margins are set by how deep it reaches on the biopsy.
The second is the shape. Cut a circle out of skin and close it and you get a pucker at each end, because the edges are different lengths. Extending it into a long ellipse with pointed ends, roughly three times as long as it is wide, lets the edges meet evenly and lie flat. That is why the scar is much longer than the growth, and no technique avoids it.
The pathology is a sampling method: The specimen is cut into slices at intervals, rather like a loaf of bread, and the cut faces are examined. It reads the margin thoroughly without displaying every point along it, which is the specific gap Mohs surgery closes. For the tumors an excision is chosen for, it is highly reliable.
Healing is by direct closure. The edges are held together while the body rebuilds collagen across the gap. Surface stitches hold for the first days; the buried dissolving stitches carry the tension for weeks, which is why lifting and straining are restricted long after the visible stitches are gone.
Skin is about two millimetres thick on the face. How deep a treatment reaches decides what it can change, and whether it treats all of the skin or scattered columns of it decides how long you take to heal.
How it works
Compare
Skin basics
This works below the skin altogether, in the fat or the muscle beneath it. Nothing applied to the surface reaches here, which is the whole reason the procedure exists — and why it is done by injection, by needle or with a blade rather than with a cream.
A peel or a scrub takes the skin off evenly from the surface down. Everything above the line goes and nothing below it is touched, which is why peels suit surface pigment and rough texture, and why the whole face flakes for a few days after.
Needles make hundreds of separate channels and leave the skin between them untouched. That untouched skin is what heals the rest, so recovery is quick — but a needle only injures the skin to start repair. It removes nothing.
The light passes through the surface and heats a column underneath it. The surface stays whole, so you leave red rather than raw — and it takes a course of sessions rather than one.
The laser removes columns of skin outright: the white gaps here are tissue that is gone, and new skin grows in from the sides. The strongest of the four, and the longest to heal.
The outer layer, and the only one anything in a jar reaches. It renews itself constantly: a cell made at the bottom takes about a month to reach the surface and flake off. Most of what a skincare product does, it does here.
The living layer underneath, holding the blood vessels, the nerves and the collagen. It is where lasting change happens and it is hard to reach: most of what is sold for the skin never gets this far.
What It Treats
−



Not the Best For
−

Pros and Cons
−
- The whole specimen is examined A pathologist reports if it came out fully.
- High cure rates About 95 percent at 5 years for an untreated basal cell.
- A short, predictable appointment Usually under an hour, on a known date.
- A neat linear scar Closed in layers along a natural line. The tidiest option.
- It works for anything The standard treatment for melanoma and other cancers.
- The scar is longer than the spot About three times the width taken out.
- The result comes later Days to a week waiting for pathology.
- The margin is sampled, not fully mapped Less than the full check Mohs does.
- More normal skin is removed A fixed margin all the way around.
- Two weeks of restriction No lifting, straining or hard exercise.
How to Prepare
−
What Happens
−
Recovery
−
Aftercare
−
Risks
−
Most excisions heal without incident. A visible scar is a certainty, not a risk. The rest below are uncommon.
In Deeper Skin Tones
−
The surgery is identical — margins, closure, pathology and cure rates do not vary with skin tone. What differs is the scar, and it is worth planning for rather than discovering.
Keloids and raised scars: Keloids and hypertrophic scars, meaning raised scars that stay raised, are more common in people with deeper skin tones. An excision is a long line held under some tension, which is exactly the setup that provokes one, and the highest-risk sites are the chest, shoulders, upper back, jawline and earlobes. If you or a close relative has ever had a keloid, say so before the surgery. It changes the plan: the ellipse may be oriented differently, closed with extra deep stitches to take tension off the surface, kept in stitches longer, and treated preventively with silicone as soon as it closes or steroid injections from a few weeks in.
Dark marks along the line: Post-inflammatory hyperpigmentation, a brown or gray line where the skin was inflamed, is common in the first months and usually fades over six to twelve months. Sun makes it darker and slower to clear, so cover the scar or use SPF 30 or higher over it for a year.
A permanently lighter line: The other possible outcome, and it contrasts more against deeper skin tones. Less common than the darkening, and less likely to fade.
Not a reason to avoid surgery: It is a reason to raise the subject early, while the choices about closure and scar prevention are still open.
Separately: Skin cancer is less common in people with deeper skin tones, is more often found late, and appears more often on skin that gets little sun. Acral melanoma, on the palms, soles and nail units, is the one most often diagnosed late. A sore that will not heal, a spot that bleeds and reopens, or a new dark streak under a nail should be examined regardless of skin tone.
If You Stop
−
There is nothing to stop taking. An excision is a single treatment and it does not wear off.
Stopping too early: Two things get stopped too early. The first is the activity restriction in the first two weeks — lifting, straining and hard exercise pull on a line whose deep stitches are still carrying all the tension, and the result is a wound that widens, stretches or occasionally splits open. A stretched scar cannot be un-stretched, and it is the most avoidable poor outcome here. The second is sun protection over a fresh scar, which leaves a darker line that takes a year or more to fade.
Stopping the follow-up is the larger one. Cure for a previously untreated basal cell carcinoma is commonly quoted around 95 percent, so a small number recur, usually within a few years and usually at the edge of the scar. The bigger reason to keep going is a new cancer somewhere else, substantially more likely after the first.
Skipping a recommended re-excision: If the pathology showed a margin that was not clear, not having the further procedure is a different matter entirely. Tumor known to be left behind keeps growing, and the surgery to remove it later is bigger than the one now.
Combining Treatments
−
Insurance Coverage
−
In the US the surgical charge is priced by the size of the excision and the body site, with a separate charge for a more complex layered closure. The pathology arrives as its own bill from the laboratory. Done to treat a diagnosed skin cancer, it is generally covered by health insurance, and your share is your plan's deductible, copay and coinsurance.
Removing a harmless growth for appearance alone is billed as cosmetic and generally not covered. A benign growth removed because it is painful, repeatedly infected, or catching on clothing is often a different story, and worth asking about rather than assuming.
Without insurance the range is wide and depends on size, site, complexity of the closure, and whether the office is hospital-affiliated. Ask for a written estimate with the specific codes, and ask separately what the pathology laboratory charges, because that bill arrives independently.
Dressings and petrolatum are out of pocket and cost very little. Silicone sheeting is not usually covered and is worth budgeting for if the scar is somewhere prone to thickening.
Ask Your Doctor
−
At-Home Versions
−
How It Compares
−








Finding a Provider
+
Excisions are done by dermatologists, plastic surgeons, general surgeons, surgical oncologists, by physician assistants and nurse practitioners in those settings, and by some primary care physicians. For a straightforward trunk or limb cancer all of these are reasonable — experience with skin surgery matters more than the specialty label.
Fair questions: what the biopsy showed including the subtype, what margin will be taken and why, roughly how long the scar will be and which direction it will run, who closes the wound, when and how you will be told the pathology result, and what happens if a margin is not clear.
Ask for the scar length: The single most useful question to ask in advance, because it is the most common surprise.
Ask to see the pathology report: The tumor type and subtype on your biopsy report decide both the margin taken and whether an excision is the right operation at all.
Red flags: a suspicious growth cut out without a biopsy first, no discussion of scar length or direction, no clear arrangement for how the result reaches you, an offer to excise a facial cancer without mentioning Mohs surgery, and any suggestion that the specimen does not need to go to a laboratory.
Myths
+
- "The scar will be about the size of the spot." Roughly three times as long, because a round hole cannot be closed flat without extending it into an ellipse. Knowing that in advance removes most of the shock.
- "If the stitches are out, it is healed." The surface is closed; the deep stitches are still carrying the tension for several more weeks. That is why the lifting restriction outlasts the visible stitches, and why scars stretch when it is ignored.
- "A clear margin means it can never come back." It means the tumor removed was fully contained in the specimen. Cure at 5 years for a previously untreated basal cell carcinoma is commonly quoted around 95 percent, and a new cancer elsewhere is more likely than a recurrence at the scar.
- "I should stop my blood thinner before skin surgery." Not on your own, and usually not at all. The bleeding is manageable; a stroke or clot is not. The prescribing doctor makes that call.
- "Keeping it dry and letting it scab over is best." Old advice. Wounds kept covered and moist with plain petrolatum heal faster and scar less than wounds left to dry and crust.
- "Vitamin E makes a scar fade." It has not been shown to help, and it causes contact dermatitis in a fair number of people. Silicone and sun protection are the two with evidence behind them.
Questions Patients Ask
+
Why is the scar so much longer than the spot?
Because a round hole cannot be closed flat. The piece taken out is an ellipse roughly three times as long as it is wide, so the edges meet evenly instead of puckering at each end. A spot the size of a pencil eraser becomes a line an inch or more long. It is geometry, not technique, and no surgeon avoids it.
How long until I get the result?
Usually 3 to 10 days, depending on the laboratory. Ask before you leave how and when you will be told, and call if you have heard nothing after about two weeks.
What happens if the margins are not clear?
A further procedure — a re-excision with a wider border, or a referral for Mohs surgery — usually within a few weeks. It is not a mistake. It is the reason the specimen went to a laboratory in the first place.
When can I exercise again?
About 2 weeks for most sites, longer for the back, shoulder and shin. The visible stitches come out sooner, and the deep stitches are still carrying the tension. Lifting or straining is what stretches or splits a wound.
Should I have Mohs surgery instead?
On the face, particularly the nose, eyelids, ears and lips, or for a tumor that is large, has vague borders, has an aggressive subtype on the biopsy, or has come back before, Mohs is often better. For a small low-risk cancer on the trunk or limbs, an excision achieves the same result in a fraction of the time and cost. Ask which category yours is in.
Will the scar fade?
It flattens and pales substantially over about a year, with most of the change in the first six months. Keeping it out of the sun and using silicone gel or sheeting once it is closed are the two things with reasonable evidence behind them. Scars on the chest, shoulders and upper back stay red and raised longest and are the likeliest to widen.
References
+
- Stratigos AJ, Dessinioti C, Garbe C, et al. European consensus-based interdisciplinary guideline for invasive cutaneous squamous cell carcinoma: Part 2. Treatment - update 2026. European journal of cancer (Oxford, England : 1990). 2026. — European journal of cancer (Oxford, England : 1990), 2026
- Stratigos AJ, Garbe C, Dessinioti C, et al. European consensus-based interdisciplinary guideline for invasive cutaneous squamous cell carcinoma: Part 2. Treatment-Update 2023. European journal of cancer (Oxford, England : 1990). 2023. — European journal of cancer (Oxford, England : 1990), 2023
- Stratigos AJ, Garbe C, Dessinioti C, et al. European interdisciplinary guideline on invasive squamous cell carcinoma of the skin: Part 2. Treatment. European journal of cancer (Oxford, England : 1990). 2020. — European journal of cancer (Oxford, England : 1990), 2020
- Bordeaux J, Blitzblau R, Aasi SZ, et al. Dermatofibrosarcoma Protuberans, Version 1.2025, NCCN Clinical Practice Guidelines In Oncology. Journal of the National Comprehensive Cancer Network : JNCCN. 2025. — Journal of the National Comprehensive Cancer Network : JNCCN, 2025
- Gauci ML, Aristei C, Becker JC, et al. Diagnosis and treatment of Merkel cell carcinoma: European consensus-based interdisciplinary guideline - Update 2022. European journal of cancer (Oxford, England : 1990). 2022. — European journal of cancer (Oxford, England : 1990), 2022
